SLC6A3 and Testicular atrophy: On the other hand, in the experimental model of cyclophosphamide-induced testicular degeneration, prior administration of DAT prevented testicular dysfunction and reduction in testosterone levels in a dose-dependent manner (Yigitaslan et al., 2014).